Despite an official ban, reusable and unsafe syringes continue to be found in markets across Pakistan, raising serious concerns about public health risks and weak enforcement of regulations.
According to Beyond Time News, recent findings suggest that banned medical syringes are still being manufactured, distributed, and sold in several regions of the country.
Unsafe Syringes Still in Use
A nationwide ban was introduced on conventional disposable syringes, but investigations show that implementation gaps remain. In some cases, syringes marketed as “auto-disable” are reportedly not functioning as intended and can still be reused.
These faulty products are particularly dangerous because they are meant to prevent reuse and reduce the spread of infections.
Read more:
Health Risks and Field Reports
Reports indicate that such syringes are available in cities including Peshawar, Multan, and Jacobabad, as well as in rural areas. Health experts warn that this situation increases the risk of blood-borne diseases such as hepatitis and HIV.
Healthcare workers have raised concerns that unqualified practitioners sometimes reuse syringes to cut costs, putting patients at serious risk.
Read more:banned-syringes-still-circulating-despite-nationwide-prohibition
Regulatory Response
The Drug Regulatory Authority of Pakistan has acknowledged compliance gaps and says efforts are underway to strengthen enforcement. Authorities have also ordered market inspections to identify violations and remove illegal products.
Officials confirmed that the production and import of conventional disposable syringes have been banned since July 2021, and registrations for such products were cancelled.
Manufacturing and Supply Concerns
Investigations suggest that some of these syringes may be linked to manufacturing units operating in industrial zones, where products are allegedly being distributed without proper regulatory oversight.
Experts believe that weak monitoring in supply chains is allowing banned medical equipment to continue circulating in the market.
Expert Warning
Health industry representatives say the problem reflects deeper weaknesses in the healthcare system. They argue that enforcement, rather than policy, is the main challenge.
They also warn that unsafe injection practices are already contributing to rising infection rates in vulnerable areas.
Conclusion
Overall, the continued availability of banned syringes highlights serious gaps in enforcement and public health safety. Experts stress that stronger monitoring and stricter action are needed to prevent further health risks and ensure patient safety across the country.
